Brain exosomes as minuscule information hub for Autism Spectrum Disorder

References

• Isola AL, Exosomes: CS. The messengers of health and disease. Curr Neuropharmacol. 2017;15(1):157–165.
   PubMed Web of Science ®Google Scholar
• Sharma P, Schiapparelli L, Cline HT. Exosomes function in cell-cell communication during brain circuit development. Curr Opin Neurobiol. 2013;23(6):997–1004.
   PubMed Web of Science ®Google Scholar
• Forrest MP, Parnell E, Penzes P. Dendritic structural plasticity and neuropsychiatric disease. Nat Rev Neurosci. 2018;19(4):215‐234.
   PubMed Web of Science ®Google Scholar
• Polanco JC, Li C, Durisic N, et al. Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons. Acta Neuropathol Commun. 2018;6(1):986.
   Web of Science ®Google Scholar
• Saeedi S, Israel S, Nagy C, et al. The emerging role of exosomes in mental disorders. Transl Psychiatry. 2019;9(1):122.
   PubMed Web of Science ®Google Scholar
• Hornung S, Dutta S, Bitan G. CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci. 2020;13:38.
   PubMed Web of Science ®Google Scholar
• Mustapic M, Eitan E, Werner JK, et al. Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci. 2017;11:278.
   PubMed Web of Science ®Google Scholar
• Kanninen KM, Bister N, Koistinaho J, et al. Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta. 2016 Mar;1862(3):403–410.
   PubMed Web of Science ®Google Scholar
• Diagnostic And Statistical Manual Of Mental Disorders, Fifth Edition https://doi.org/https://doi.org/10.1176/appi.books.9780890425596
   Google Scholar
• Volkmar, F,, Rogers, S., Paul, R. (Eds.).(2014). Handbook of autism and pervasive developmental disorders. 4th ed. Hoboken, NJ: John Wiley & Sons, Inc. ISBN: 9781118107027 (2 vols.)
   Google Scholar
• Christensen DL, Baio J, Van Naarden Braun K, et al. Centers for Disease Control and Prevention (CDC). prevalence and characteristics of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ. 2016;65(3):1–23.
   PubMed Web of Science ®Google Scholar
• Casanova MF, Frye RE, Gillberg C, et al. Editorial: comorbidity and Autism Spectrum Disorder. Front Psychiatry. 2020;11:617395.
   PubMed Web of Science ®Google Scholar
• Landa RJ. Efficacy of early interventions for infants and young children with, and at risk for, autism spectrum disorders. Int Rev Psychiatry. 2018;30(1):25–39.
   PubMed Web of Science ®Google Scholar
• Chawarska K, Klin A, Paul R, et al. Autism spectrum disorder in the second year: stability and change in syndrome expression. J Child Psychol Psychiatry. 2007 Feb;48(2):128–138.
   PubMed Web of Science ®Google Scholar
• Sheldrick RC, Maye MP, Carter AS. Age at first identification of Autism Spectrum Disorder: an analysis of two US surveys. J Am Acad Child Adolesc Psychiatry. 2017;56(4):313–320.
   PubMed Web of Science ®Google Scholar
• Goldani AA, Downs SR, Widjaja F, et al. Biomarkers in autism. Front Psychiatry. 2014;5:100.
   PubMed Web of Science ®Google Scholar
• Shen, Liming & Zhao, Yuxi & Zhang, Huajie & Feng, Chengyun & Gao, Yan & Zhao, Danqing & Xia, Sijian & Hong, Qi & Iqbal, Javed & Liu, Xu & Yao, Fang. (2019). Advances in Biomarker Studies in Autism Spectrum Disorders. doi:https://doi.org/10.1007/978-3-030-05542-4_11.
   Google Scholar
• Shen L, Liu X, Zhang H, et al. Biomarkers in autism spectrum disorders: current progress. Clin Chim Acta. 2020Mar;502:41–54.
   PubMed Web of Science ®Google Scholar
• Ristori MV, Mortera SL, Marzano V, et al. Proteomics and metabolomics approaches towards a functional insight onto AUTISM spectrum disorders: phenotype stratification and biomarker discovery. Int J Mol Sci. 2020;21(17):6274.
   Web of Science ®Google Scholar
• Frye RE, Vassall S, Kaur G, et al. Emerging biomarkers in autism spectrum disorder: a systematic review. Ann Transl Med. 2019;7(23):792. Kawikova I, Askenase PW. Diagnostic and therapeutic potentials of exosomes in CNS diseases. Brain Res 2015;1617:63–71.
   PubMed Web of Science ®Google Scholar
• Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012;14(3):281–292.
   PubMedGoogle Scholar
• Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68(11):1095–1102.
   PubMed Web of Science ®Google Scholar
• Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82(2):477–488.
   PubMed Web of Science ®Google Scholar
• Leppa VM, Kravitz SN, Martin CL, et al. Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families. Am J Hum Genet. 2016;99(3):540–554.
   PubMed Web of Science ®Google Scholar
• Jang W, Kim Y, Han E, et al. Chromosomal microarray analysis as a first-tier clinical diagnostic test in patients with developmental delay/intellectual disability, Autism Spectrum Disorders, and multiple congenital anomalies: a prospective multicenter study in Korea. Ann Lab Med. 2019 May;39(3):299–310.
   PubMed Web of Science ®Google Scholar
• Nisar S, Hashem S, Bhat AA, et al. Association of genes with phenotype in autism spectrum disorder. Aging (Albany NY). 2019;11(22):10742–10770.
   PubMedGoogle Scholar
• Huguet G, Ey E, Bourgeron T. The genetic landscapes of autism spectrum disorders. Annu. Rev. Genomics Hum Genet. 2013;14(1):191–213.
   PubMed Web of Science ®Google Scholar
• Chaste P, Klei L, Sanders SJ, et al. A genome-wide association study of autism using the Simons Simplex Collection: does reducing phenotypic heterogeneity in autism increase genetic homogeneity? Biol Psychiatry. 2015;77(9):775–784.
   PubMed Web of Science ®Google Scholar
• Hu VW, Lai Y. Developing a predictive gene classifier for Autism Spectrum Disorders based upon differential gene expression profiles of phenotypic subgroups. N Am J Med Sci (Boston). 2013;6:3.
   Google Scholar
• Kalsner L, Twachtman-Bassett J, Tokarski K, et al. Genetic testing including targeted gene panel in a diverse clinical population of children with autism spectrum disorder: findings and implications. Mol Genet Genomic Med. 2018Mar;6(2):171–185. Epub 2017 Dec 21.
   PubMed Web of Science ®Google Scholar
• Quesnel-Vallières M, Weatheritt RJ, Cordes SP, et al. Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nat Rev Genet. 2019;20(1):51–63.
   PubMed Web of Science ®Google Scholar
• Griesi-Oliveira K, Fogo MS, Pinto BGG, et al. Transcriptome of iPSC-derived neuronal cells reveals a module of co-expressed genes consistently associated with autism spectrum disorder. Mol Psychiatry. 2020; DOI:https://doi.org/10.1038/s41380-020-0669-9.
   Google Scholar
• Zhang R, Zhou J, Ren J, et al. Transcriptional and splicing dysregulation in the prefrontal cortex in valproic acid rat model of autism. Reprod Toxicol. 2018 Apr;77:53–61.
   PubMed Web of Science ®Google Scholar
• Gregg JP, Lisa L, Colin AB, et al. Gene expression changes in children with autism. Genomics. 2008;91(1):22–29.
   PubMed Web of Science ®Google Scholar
• Filosi M, Kam-Thong T, Essioux L, et al. Transcriptome signatures from discordant sibling pairs reveal changes in peripheral blood immune cell composition in Autism Spectrum Disorder. Transl Psychiatry. 2020 Apr 14;10(1):106.
   PubMed Web of Science ®Google Scholar
• Horiuchi F, Yoshino Y, Kumon H, et al. identification of aberrant innate and adaptive immunity based on changes in global gene expression in the blood of adults with autism spectrum disorder. J Neuroinflammation. 2021;18(1):102. Published 2021 Apr 30.
   PubMed Web of Science ®Google Scholar
• Ciernia AV, LaSalle J. The landscape of DNA methylation amid a perfect storm of autism aetiologies. Nat Rev Neurosci. 2016;17(7):411–423.
   PubMed Web of Science ®Google Scholar
• Nguyen A, Rauch TA, Pfeifer GP, et al. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J. 2010;24(8):3036–3051.
   PubMed Web of Science ®Google Scholar
• Andrews SV, Sheppard B, Windham GC, et al. Case-control meta-analysis of blood DNA methylation and autism spectrum disorder. Mol Autism. 2018;9(1):40.
   PubMed Web of Science ®Google Scholar
• Jacob C, Nguyen TT, Weißflog L, et al. PPP2R2C as a candidate gene of a temperament and character trait-based endophenotype of ADHD. ADHD Attention Deficit and Hyperactivity Disorders. 2012;4(3):145–152.
   Google Scholar
• Kimura R, Nakata M, Funabiki Y, et al. An epigenetic biomarker for adult high-functioning autism spectrum disorder. Sci Rep. 2019;9(1):13662.
   PubMed Web of Science ®Google Scholar
• Emond P, Mavel S, Aïdoud N, et al. GC-MS-based urine metabolic profiling of autism spectrum disorders. Anal Bioanal Chem. 2013 Jun;405(15):5291–5300.
   PubMed Web of Science ®Google Scholar
• West PR, Amaral DG, Bais P, et al. Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children. PLoS ONE. 2014;9(11):e112445.
   PubMed Web of Science ®Google Scholar
• Khemakhem AM, Frye RE, El-Ansary A, et al. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers. Metab Brain Dis. 2017 Dec;32(6):1983–1997.
   PubMed Web of Science ®Google Scholar
• Graham SF, Turkoglu O, Yilmaz A, et al. Targeted metabolomics highlights perturbed metabolism in the brain of autism spectrum disorder sufferers. Metabolomics. 2020 Apr 24;16(5):59.
   PubMed Web of Science ®Google Scholar
• Kurochkin I, Khrameeva E, Tkachev A, et al. Metabolome signature of autism in the human prefrontal cortex. Commun Biol. 2019;2(1):234.
   PubMed Web of Science ®Google Scholar
• Wolff JJ, Jacob S, Elison JT. The journey to autism: insights from neuroimaging studies of infants and toddlers. Dev Psychopathol. 2018;30(2):479–495.
   PubMed Web of Science ®Google Scholar
• Hazlett HC, Gu H, Munsell BC, et al. Early brain development in infants at high risk for autism spectrum disorder. Nature. 2017;542(7641):348–351.
   PubMed Web of Science ®Google Scholar
• Amaral DG, Li D, Libero L, et al. In pursuit of neurophenotypes: the consequences of having autism and a big brain. Autism Res. 2017 May;10(5):711–722.
   PubMed Web of Science ®Google Scholar
• Emerson RW, Adams C, Nishino T, et al. Functional neuroimaging of high-risk 6-month-old infants predicts a diagnosis of autism at 24 months of age. Sci Transl Med. 2017;9(393):eaag2882.
   PubMed Web of Science ®Google Scholar
• Li D, Karnath HO, Xu X. Candidate biomarkers in children with Autism Spectrum Disorder: a review of MRI studies. Neurosci Bull. 2017 Apr;33(2):219–237.
   PubMed Web of Science ®Google Scholar
• Hiremath CS, Sagar KJV, Yamini BK, et al. Emerging behavioral and neuroimaging biomarkers for early and accurate characterization of autism spectrum disorders: a systematic review. Transl Psychiatry. 2021;11(1):42. Published 2021 Jan 13.
   PubMed Web of Science ®Google Scholar
• Xu L, Liu Y, Yu J, et al. Characterizing autism spectrum disorder by deep learning spontaneous brain activity from functional near-infrared spectroscopy. J Neurosci Methods. 2020;331:108538.
   PubMed Web of Science ®Google Scholar
• Xu L, Geng X, He X, et al. Prediction in autism by deep learning short-time spontaneous hemodynamic fluctuations. Front Neurosci. 2019;13:1120.
   PubMed Web of Science ®Google Scholar
• Song JW, Yoon NR, Jang SM, et al. Neuroimaging-based deep learning in Autism Spectrum Disorder and attention-deficit/hyperactivity disorder. Soa Chongsonyon Chongsin Uihak. 2020;31(3):97–104.
   PubMedGoogle Scholar
• Subah FZ, Deb K, Dhar PK, et al. A deep learning approach to predict Autism Spectrum Disorder using multisite resting-state fMRI. Appl Sci. 2021;11(8):3636.
   Google Scholar
• Willemsen MH, Valles A, Kirkels LA, et al. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J Med Genet. 2011;48(12):810–818.
   PubMed Web of Science ®Google Scholar
• Stappert L, Klaus F, MicroRNAs BO. Engage in complex circuits regulating adult neurogenesis. Front Neurosci. 2018 Nov;5(12):707.
   Web of Science ®Google Scholar
• NFM OL, Kole K, Glennon JC, et al. Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism. Neurobiol Dis. 2015 Aug;80:42–53.
   PubMed Web of Science ®Google Scholar
• Wu YE, Parikshak NN, Belgard TG, et al. Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder. Nat Neurosci. 2016;19(11):1463‐1476.
   Web of Science ®Google Scholar
• Kong SW, Collins CD, Shimizu-Motohashi Y, et al. Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLoS One. 2012;7(12):e49475.
   PubMed Web of Science ®Google Scholar
• Mundalil Vasu M, Anitha A, Thanseem I, et al. Serum microRNA profiles in children with autism. Mol Autism. 2014;5(1):40.
   PubMed Web of Science ®Google Scholar
• Wu X, Li W, Zheng Y. Recent Progress on Relevant microRNAs in Autism Spectrum Disorders. Int J Mol Sci. 2020;21(16):5904. Published 2020 Aug 17.
   Web of Science ®Google Scholar
• Ozkul Y, Taheri S, Bayram KK, et al. A heritable profile of six miRNAs in autistic patients and mouse models. Sci Rep. 2020;10(1):9011. Published 2020 Jun 9.
   PubMed Web of Science ®Google Scholar
• Abraham JR, Szoko N, Barnard J, et al. Proteomic investigations of Autism brain identify known and novel pathogenetic processes. Sci Rep. 2019b;9(1):13118.
   PubMed Web of Science ®Google Scholar
• Szoko N, McShane AJ, Natowicz MR. Proteomic explorations of autism spectrum disorder. Autism Res. 2017;10(9):1460–1469.
   PubMed Web of Science ®Google Scholar
• Abraham J, Szoko N, Natowicz MR. Proteomic investigations of Autism Spectrum Disorder: past findings, current challenges, and future prospects. Adv Exp Med Biol. 2019a;1118:235–252.
   PubMed Web of Science ®Google Scholar
• Hewitson L, Mathews JA, Devlin M, et al. Blood biomarker discovery for autism spectrum disorder: a proteomic analysis. PLoS One. 2021;16(2):e0246581. Published 2021 Feb 24.
   PubMed Web of Science ®Google Scholar
• Suganya V, Geetha A, Sujatha S. Urine proteome analysis to evaluate protein biomarkers in children with autism. Clin Chim Acta. 2015 Oct;23(450):210–219.
   Web of Science ®Google Scholar
• Ngounou Wetie AG, Wormwood KL, Russell S, et al. A pilot proteomic analysis of salivary biomarkers in Autism Spectrum Disorder. Autism Res. 2015 Jun;8(3):338–350.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zheng P, and Zou X. Peripheral blood S100B levels in Autism Spectrum Disorder: a systematic review and meta-analysis. J Autism Dev Disord. 2020 Aug;51(8):2569-2577. doi: https://doi.org/10.1007/s10803-020-04710-1. PMID: 33006697; PMCID: PMC8254719.
   Google Scholar
• Lee JC, Kim SJ, Hong S, et al. Diagnosis of Alzheimer’s disease utilising amyloid and tau as fluid biomarkers. Exp Mol Med. 2019;51(5):1–10. Published 2019 May 9.
   Web of Science ®Google Scholar
• Fiandaca MS, Kapogiannis D, Mapstone M, et al. identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11(6):600‐7.e1.
   PubMed Web of Science ®Google Scholar
• Jia L, Qiu Q, Zhang H, et al. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15(8): 1071–1080.
   PubMed Web of Science ®Google Scholar
• Momeni N, Bergquist J, Brudin L, et al. A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry. 2012;2(3):e91.
   PubMed Web of Science ®Google Scholar
• Pichitpunpong C, Thongkorn S, Kanlayaprasit S, et al. Phenotypic subgrouping and multi-omics analyses reveal reduced diazepam-binding inhibitor (DBI) protein levels in autism spectrum disorder with severe language impairment. PLoSONE. 2019;14(3):e0214198.
   PubMed Web of Science ®Google Scholar
• Shen L, Feng C, Zhang K, et al. Proteomics study of Peripheral Blood Mononuclear Cells (PBMCs) in Autistic Children. Front Cell Neurosci. 2019;13:105.
   PubMed Web of Science ®Google Scholar
• Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Sig Transduct Target Ther. 2020;5(1):145.
   PubMed Web of Science ®Google Scholar
• Osaki M, Exosomes OF. Their role in cancer progression. Yonago Acta Med. 2019;62(2):182–190.
   PubMed Web of Science ®Google Scholar
• Tsilioni I, Theoharides TC. Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β. J Neuroinflammation. 2018;15(1):239.
   PubMed Web of Science ®Google Scholar
• Perets N, Hertz S, London M, et al. Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice. Mol Autism. 2018;9(1):57.
   PubMed Web of Science ®Google Scholar
• Qin Y, Cao L, Zhang H, et al. Whole-transcriptome analysis of serum neuron-derived exosomes reveals specific signature for autism spectrum disorder in Chinese children. Cited 2021 Jul 23, https://www.researchsquare.com/article/rs-735519/v1.
   Google Scholar
• Guang S, Pang N, Deng X, et al. Synaptopathology involved in Autism Spectrum Disorder. Front Cell Neurosci. 2018;12:470.
   PubMed Web of Science ®Google Scholar
• Takano T. Role of microglia in autism: recent advances. Dev Neurosci. 2015;37(3):195–202.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Sapone A, Senger S, et al. Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016;7(1):1–17. Alessio N, Brigida AL, Peluso G, Antonucci N, Galderisi U, Siniscalco D. Stem Cell-Derived Exosomes in Autism Spectrum Disorder. Int J Environ Res Public Health. 2020 Feb 4;17(3):944.
   PubMed Web of Science ®Google Scholar
• Gillet V, Hunting DJ, Turing Revisited: TL. Decoding the microRNA messages in brain extracellular vesicles for early detection of neurodevelopmental disorders. Curr Environ Health Rep. 2016;3(3):188‐201.
   PubMedGoogle Scholar
• Quek C, Bellingham SA, Jung CH, et al. Defining the purity of exosomes required for diagnostic profiling of small RNA suitable for biomarker discovery. RNA Biol. 2017;14(2):245–258.
   PubMed Web of Science ®Google Scholar
• Sódar BW, Á K, Visnovitz T, et al. Best practice of identification and proteomic analysis of extracellular vesicles in human health and disease. Expert Rev Proteomics. 2017 Dec;14(12):1073–1090.
   PubMed Web of Science ®Google Scholar